Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

LIMOZIN

Class 5Status: Objected
Trademark Logo
Application Number5737557
Trademark Status
Objected
Trademark Class5
Application Date2022-12-26
Proprietor NameANEXAS PHARMACEUTICALS PRIVATE LIMITED
Appropriate OfficeDELHI
StateUTTAR PRADESH
Trademark TypeDEVICE
User Details23/03/2021
Agent NameSONU ASWANI[32912]
Agent AddressHouse 7, Near Kabir Aashram,Kalakunj, Maruti Estate,Agra-282010, Uttar Pradesh
Goods And Services Details[CLASS : 5] Medicinal and pharmaceutical preparations included in Class 05

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
LIMOZIN5Objected
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about LIMOZIN.

What is the status of trademark application 5737557?
The current status of trademark application 5737557 for LIMOZIN is Objected.
What is the trademark class of LIMOZIN?
LIMOZIN is registered under trademark class 5.
Who is the proprietor of LIMOZIN?
The proprietor of LIMOZIN is ANEXAS PHARMACEUTICALS PRIVATE LIMITED.
When was trademark application 5737557 filed?
Trademark application 5737557 for LIMOZIN was filed on 2022-12-26.